These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9539361)

  • 21. Variation among pathologists in histologic grading of canine cutaneous mast cell tumors.
    Northrup NC; Harmon BG; Gieger TL; Brown CA; Carmichael KP; Garcia A; Latimer KS; Munday JS; Rakich PM; Richey LJ; Stedman NL; Cheng AL; Howerth EW
    J Vet Diagn Invest; 2005 May; 17(3):245-8. PubMed ID: 15945380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canine mast cell tumors.
    Hess PW
    Vet Clin North Am; 1977 Feb; 7(1):133-43. PubMed ID: 403650
    [No Abstract]   [Full Text] [Related]  

  • 23. Production of a monoclonal antibody against canine GMP-140 (P-selectin) and studies of its vascular distribution in canine tissues.
    Doré M; Hawkins HK; Entman ML; Smith CW
    Vet Pathol; 1993 May; 30(3):213-22. PubMed ID: 7687399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canine mast cell diseases.
    Cook JE
    Natl Cancer Inst Monogr; 1969 Aug; 32():267-83. PubMed ID: 4981716
    [No Abstract]   [Full Text] [Related]  

  • 25. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog.
    Preziosi R; Morini M; Sarli G
    J Vet Diagn Invest; 2004 Nov; 16(6):554-61. PubMed ID: 15586571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors.
    Jaffe MH; Hosgood G; Taylor HW; Kerwin SC; Hedlund CS; Lopez MK; Davidson JR; Miller DM; Paranjpe M
    Vet Pathol; 2000 Jan; 37(1):40-6. PubMed ID: 10643979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple, resolving, cutaneous histiocytoma in a dog.
    Bender WM; Muller GH
    J Am Vet Med Assoc; 1989 Feb; 194(4):535-7. PubMed ID: 2537810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells.
    Meyer A; Gruber AD; Klopfleisch R
    Vet Pathol; 2012 Nov; 49(6):988-97. PubMed ID: 22446323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous histiocytomas of dogs.
    Howard EB; Nielsen SW
    Natl Cancer Inst Monogr; 1969 Aug; 32():321-7. PubMed ID: 4310776
    [No Abstract]   [Full Text] [Related]  

  • 30. Ultrasound-guided cytology of spleen and liver: a prognostic tool in canine cutaneous mast cell tumor.
    Stefanello D; Valenti P; Faverzani S; Bronzo V; Fiorbianco V; Pinto da Cunha N; Romussi S; Cantatore M; Caniatti M
    J Vet Intern Med; 2009; 23(5):1051-7. PubMed ID: 19656285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis and mitosis in tumours of the skin and subcutaneous tissues of the dog.
    Martin De Las Mulas J; Millan Y; Ruiz-Villamor E; Bautista MJ; Rollon E; Espinosa De Los Monteros A
    Res Vet Sci; 1999 Apr; 66(2):139-46. PubMed ID: 10208892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An immunohistochemical study of vitamin D receptor expression in canine cutaneous mast cell tumours.
    Russell DS; Rassnick KM; Erb HN; Vaughan MM; McDonough SP
    J Comp Pathol; 2010; 143(2-3):223-6. PubMed ID: 20334872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOXP3, CD208, and CD206 Expression in Canine Cutaneous Histiocytoma.
    Belluco S; Sammarco A; Sapin P; Lurier T; Marchal T
    Vet Pathol; 2020 Sep; 57(5):599-607. PubMed ID: 32783525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the expression of P-selectin, ICAM-1, and TNF-alpha in bacteria-free lesional skin of atopic dogs with low-to-mild inflammation.
    de Mora F; de la Fuente C; Jasmin P; Gatto H; Marco A; Ferrer L; Fondati A; Fondevila D; Torres R
    Vet Immunol Immunopathol; 2007 Feb; 115(3-4):223-9. PubMed ID: 17166594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphologic and biologic characteristics of the canine cutaneous histiocytoma.
    Taylor DO; Dorn CR; Luis OH
    Cancer Res; 1969 Jan; 29(1):83-92. PubMed ID: 4303447
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
    Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
    Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cutaneous mastocytoma in dogs].
    Nevole M; Halouzka R; Cerný L
    Vet Med (Praha); 1972 Jan; 17(1):33-8. PubMed ID: 4623804
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnostic immunohistochemistry of canine round cell tumors.
    Sandusky GE; Carlton WW; Wightman KA
    Vet Pathol; 1987 Nov; 24(6):495-9. PubMed ID: 3137715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies for the diagnosis of canine mastocytoma.
    Sasai K; Katoh M; Fujita D; Yamashita M; Constantinoiu CC; Matsubayashi M; Tani H; Baba E
    Hybridoma (Larchmt); 2007 Jun; 26(3):162-7. PubMed ID: 17600498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
    Kiupel M; Webster JD; Miller RA; Kaneene JB
    J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.